DZ2254A1 - Analogues d'indazole nouveaux. - Google Patents

Analogues d'indazole nouveaux.

Info

Publication number
DZ2254A1
DZ2254A1 DZ970104A DZ970104A DZ2254A1 DZ 2254 A1 DZ2254 A1 DZ 2254A1 DZ 970104 A DZ970104 A DZ 970104A DZ 970104 A DZ970104 A DZ 970104A DZ 2254 A1 DZ2254 A1 DZ 2254A1
Authority
DZ
Algeria
Prior art keywords
indazole analogues
new indazole
new
analogues
indazole
Prior art date
Application number
DZ970104A
Other languages
English (en)
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2254A1 publication Critical patent/DZ2254A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ970104A 1996-06-25 1997-06-24 Analogues d'indazole nouveaux. DZ2254A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2038596P 1996-06-25 1996-06-25

Publications (1)

Publication Number Publication Date
DZ2254A1 true DZ2254A1 (fr) 2002-12-18

Family

ID=21798354

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970104A DZ2254A1 (fr) 1996-06-25 1997-06-24 Analogues d'indazole nouveaux.

Country Status (43)

Country Link
US (1) US6040329A (fr)
EP (1) EP0912558B1 (fr)
JP (1) JP3152940B2 (fr)
KR (1) KR20000022516A (fr)
CN (1) CN1080260C (fr)
AP (1) AP1025A (fr)
AR (1) AR007456A1 (fr)
AT (1) ATE244713T1 (fr)
AU (1) AU716376B2 (fr)
BG (1) BG64052B1 (fr)
BR (1) BR9712782A (fr)
CA (1) CA2258285C (fr)
CO (1) CO4900056A1 (fr)
CZ (1) CZ423398A3 (fr)
DE (1) DE69723447T2 (fr)
DK (1) DK0912558T3 (fr)
DZ (1) DZ2254A1 (fr)
EA (1) EA002274B1 (fr)
ES (1) ES2201299T3 (fr)
GT (1) GT199700075A (fr)
HK (1) HK1018700A1 (fr)
HN (1) HN1997000079A (fr)
HR (1) HRP970350B1 (fr)
HU (1) HUP9903009A3 (fr)
ID (1) ID18579A (fr)
IL (1) IL127036A (fr)
IS (1) IS4910A (fr)
MA (1) MA24225A1 (fr)
MY (1) MY116915A (fr)
NO (1) NO986103D0 (fr)
NZ (1) NZ332752A (fr)
OA (1) OA10934A (fr)
PA (1) PA8432301A1 (fr)
PL (1) PL330974A1 (fr)
PT (1) PT912558E (fr)
SI (1) SI0912558T1 (fr)
SK (1) SK176598A3 (fr)
TN (1) TNSN97108A1 (fr)
TR (1) TR199802685T2 (fr)
TW (1) TW434237B (fr)
WO (1) WO1997049702A1 (fr)
YU (1) YU60198A (fr)
ZA (1) ZA975581B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997048697A1 (fr) 1996-06-19 1997-12-24 Rhone-Poulenc Rorer Limited Composes azabicycliques substitues et leur utilisation en tant qu'inhibiteurs de la production de tnf et de la photodiesterase cyclique d'amp
YU11299A (sh) * 1996-09-04 2001-07-10 Pfizer Inc. Derivati indazola
US6248746B1 (en) 1998-01-07 2001-06-19 Euro-Celtique S.A. 3-(arylalkyl) xanthines
CA2309175A1 (fr) * 1997-11-04 1999-05-14 Pfizer Products Inc. Composes therapeutiquement actifs obtenus par remplacement du catechol par un bio-isostere d'indazole dans des inhibiteurs de pde4
ATE290002T1 (de) * 1999-12-23 2005-03-15 Icos Corp Cyclische amp spezifische phosphodiesterase inhibitoren
US6362213B1 (en) 1999-12-23 2002-03-26 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
US6953774B2 (en) 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
US7205320B2 (en) 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
US7153871B2 (en) 2001-01-22 2006-12-26 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
US6982274B2 (en) * 2001-04-16 2006-01-03 Eisai Co., Ltd. 1H-indazole compound
PT1908463E (pt) 2001-12-14 2011-12-19 Merck Serono Sa Método para induzir a ovulação utilizando um modulador de nível camp não polipeptídico
BR0313000A (pt) 2002-07-19 2005-07-12 Memory Pharm Corp Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente
NZ537724A (en) 2002-07-19 2006-10-27 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
BR0315705A (pt) * 2002-11-19 2005-09-06 Memory Pharm Corp Inibidores de fosfodiesterase-4
WO2004094411A1 (fr) * 2003-04-18 2004-11-04 Memory Pharmaceuticals Corporation Derives du pyrazole inhibiteurs de la phosphodiesterase 4
US20090048255A1 (en) * 2003-07-21 2009-02-19 Schumacher Richard A Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
WO2006044528A1 (fr) * 2004-10-15 2006-04-27 Memory Pharmaceuticals Corporation Derives de pyrazole utilises en tant qu'inhibiteurs de phosphodiesterase 4
US7601847B2 (en) 2004-10-26 2009-10-13 Wyeth Preparation and purification of 4-(indazol-3-yl)phenols
WO2006129158A2 (fr) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiesterase de type iv
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
US7781460B2 (en) 2005-09-05 2010-08-24 Ranbaxy Laboratories Limited Substituted indazoles as inhibitors of phosphodiesterase type-IV
WO2007031838A1 (fr) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
CA2625153A1 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (fr) 2006-05-09 2011-10-19 Braincells, Inc. Neurogénèse par modulation de l'angiotensine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
NZ599597A (en) * 2009-10-30 2013-05-31 Janssen Pharmaceutica Nv IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
WO2013106547A1 (fr) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation
US20150125438A1 (en) * 2012-07-20 2015-05-07 Sang Jae Kim Anti-Inflammatory Peptides and Composition Comprising the Same
WO2015166370A1 (fr) 2014-04-28 2015-11-05 Pfizer Inc. Composés hétéroaromatiques et leur utilisation en tant que ligands de la dopamine d1
KR20220167441A (ko) * 2021-06-11 2022-12-21 주식회사 메타센테라퓨틱스 신규한 인돌 유도체 및 이의 최종당화산물 관련 질환의 치료 용도
KR20220167804A (ko) * 2021-06-11 2022-12-22 주식회사 메타센테라퓨틱스 인돌 유도체를 포함하는 최종당화산물 관련 질환의 치료용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB753573A (en) * 1953-06-17 1956-07-25 Ici Ltd New dyestuffs intermediates
GB8707051D0 (en) * 1986-04-15 1987-04-29 Ici America Inc Heterocyclic carboxamides
PT100441A (pt) * 1991-05-02 1993-09-30 Smithkline Beecham Corp Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
TW223004B (fr) * 1991-11-25 1994-05-01 Sumitomo Chemical Co
US5444038A (en) * 1992-03-09 1995-08-22 Zeneca Limited Arylindazoles and their use as herbicides
AU677776B2 (en) * 1992-04-02 1997-05-08 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US5554620A (en) * 1993-09-14 1996-09-10 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
JPH07215952A (ja) * 1993-12-06 1995-08-15 Otsuka Pharmaceut Factory Inc カテコール誘導体
WO1996012720A1 (fr) * 1994-10-20 1996-05-02 Pfizer Inc. Tetrahydropyrazolopyridines bicycliques et leur emploi comme medicaments

Also Published As

Publication number Publication date
MY116915A (en) 2004-04-30
CA2258285C (fr) 2002-11-26
PL330974A1 (en) 1999-06-21
OA10934A (en) 2002-02-18
CZ423398A3 (cs) 1999-12-15
ATE244713T1 (de) 2003-07-15
MA24225A1 (fr) 1997-12-31
CO4900056A1 (es) 2000-03-27
EA002274B1 (ru) 2002-02-28
NZ332752A (en) 2001-04-27
PA8432301A1 (es) 1999-12-27
HK1018700A1 (en) 1999-12-30
HN1997000079A (es) 1997-12-26
TW434237B (en) 2001-05-16
YU60198A (sh) 1999-09-27
AR007456A1 (es) 1999-10-27
PT912558E (pt) 2003-11-28
HRP970350B1 (en) 2003-04-30
IS4910A (is) 1998-11-27
BR9712782A (pt) 1999-12-07
HUP9903009A2 (hu) 2000-05-28
US6040329A (en) 2000-03-21
JP3152940B2 (ja) 2001-04-03
NO986103L (no) 1998-12-23
JPH11514668A (ja) 1999-12-14
DK0912558T3 (da) 2003-08-18
GT199700075A (es) 1998-12-04
BG64052B1 (bg) 2003-11-28
ID18579A (id) 1998-04-23
AP1025A (en) 2001-11-19
HUP9903009A3 (en) 2002-01-28
EA199801047A1 (ru) 1999-06-24
WO1997049702A1 (fr) 1997-12-31
NO986103D0 (no) 1998-12-23
TR199802685T2 (xx) 1999-03-22
HRP970350A2 (en) 1998-06-30
SI0912558T1 (en) 2003-10-31
DE69723447D1 (de) 2003-08-14
EP0912558A1 (fr) 1999-05-06
AU716376B2 (en) 2000-02-24
ES2201299T3 (es) 2004-03-16
AP9701020A0 (en) 1997-07-31
CA2258285A1 (fr) 1997-12-31
CN1223651A (zh) 1999-07-21
DE69723447T2 (de) 2003-12-24
ZA975581B (en) 1998-12-24
IL127036A (en) 2001-06-14
AU2785797A (en) 1998-01-14
CN1080260C (zh) 2002-03-06
SK176598A3 (en) 2000-06-12
EP0912558B1 (fr) 2003-07-09
TNSN97108A1 (fr) 2005-03-15
KR20000022516A (ko) 2000-04-25
IL127036A0 (en) 1999-09-22
BG103056A (en) 1999-10-29

Similar Documents

Publication Publication Date Title
DZ2254A1 (fr) Analogues d'indazole nouveaux.
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
DE59707441D1 (de) Förderpumpe
ID16298A (id) Turunan-turunan 1,2,3,4-tetrahidronaftalena yang disubstitusi
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DE69618634D1 (de) 1,4-benzodioxin-derivate
NO992059D0 (no) 2-metoksyfenylpiperazinderivater
BR9709521A (pt) "3-Cianoaril-pirazóis"
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
FR2716157B1 (fr) Agencement d'ancrage.
FR2720911B1 (fr) Caisse d'exposition-malle.
FR2724962B3 (fr) Tuile d'avant-toit sous-faitiere.
IT1283187B1 (it) "elettrovalvola."
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
ES1034285Y (es) "expositor".
IT1274643B (it) Costruzione rapida "isodomus".
ES1038172Y (es) "caja-contenedor".
ITTO970892A0 (it) Salame all'erbaluce di caluso.
BR9606017A (pt) "Enrotrilan"
ITAQ960003A1 (it) Confetto "tartufo".